Dr. Christopher Andrews joins M Pharmaceutical board

Christopher Andrews, MD, MSc, FRCPC, a gastroenterologist with the University of Calgary in Canada, has joined the M Pharmaceutical board of directors.

Advertisement

M Pharmaceutical is focused on developing biomedical technologies for obesity and diabetes.

Dr. Andrews focuses on stomach disorders and physiology. He completed advanced training in GI motility and function, as well as a master’s degree in clinical health research, at Mayo Clinic in Rochester, Minn.

More articles on gastroenterology:
Commonwealth Laboratories launches IBS blood test
Global capsule endoscopy market to grow at 11% until 2019: 4 key trends
18k Stretta procedures performed since its introduction

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.